Celebrex
In brief
- In our pharmacy, you can buy celebrex without a prescription, with delivery in 9–21 days throughout Australia. Discreet and anonymous packaging.
- Celebrex (celecoxib) is used to treat osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute pain including menstrual pain, juvenile idiopathic arthritis and to reduce polyps in familial adenomatous polyposis; it works as a selective COX‑2 inhibitor, reducing prostaglandin synthesis and inflammation.
- Usual doses vary by indication: osteoarthritis 200 mg once daily or 100 mg twice daily; rheumatoid arthritis 100–200 mg twice daily; ankylosing spondylitis 200 mg once daily or 100 mg twice daily; acute pain initial 400 mg then 200 mg if needed on day 1, then 200 mg twice daily; FAP 400 mg twice daily; pediatric doses for JIA are weight‑based (often ~50–100 mg twice daily).
- Administered orally as capsules (commonly 100 mg and 200 mg) or, in some markets, as an oral solution (Elyxyb® 25 mg/mL); take with or without food.
- Celecoxib generally starts to work within about 1 hour for pain relief, with peak effects developing over 2–3 hours.
- The duration of effect is typically around 12 hours, with some patients experiencing up to 24 hours of symptom control depending on dose and individual response.
- Avoid or limit alcohol while taking celecoxib — alcohol can increase the risk of gastrointestinal bleeding and stomach irritation.
- The most common side effects are dyspepsia (indigestion), abdominal pain and headache; other frequent effects include nausea, diarrhoea, dizziness, rash, hypertension and peripheral oedema.
- Would you like to try celebrex without a prescription?
Basic Celebrex Information
- INN (International Nonproprietary Name): Celecoxib
- Brand Names Available In Australia: Not specified
- ATC Code: M01AH01 — M = Musculo‑skeletal System; 01AH = Anti‑inflammatory and Antirheumatic Products, Non‑Steroids, Coxibs Subgroup (Selective COX‑2 Inhibitors).
- Forms & Dosages: Capsules 100 mg and 200 mg (common blister packs of 10, 30, 60); oral solution 25 mg/mL (Elyxyb®, marketed in the US only) — capsules are the usual form for arthritis and acute pain.
- Manufacturers In Australia: Not specified
- Registration Status In Australia: Not specified
- OTC / Rx Classification: Prescription Only (RX) worldwide.
Critical Warnings & Restrictions
High‑Risk Groups (Elderly, Pregnancy, Chronic Illness)
People worry about safety if they are older, pregnant, or have long‑term conditions such as heart, kidney or liver disease.
Absolute contraindications include known allergy to celecoxib, sulfonamides, NSAIDs or any inactive ingredients.
A history of asthma, urticaria or other allergic reactions to aspirin or other NSAIDs is also an absolute contraindication.
Active gastrointestinal bleeding or peptic ulcer disease is an absolute contraindication to use.
Relative contraindications include cardiovascular disease or risk factors, uncontrolled hypertension, heart failure, renal or hepatic impairment and fluid‑retaining states.
For patients in high‑risk groups start at the lowest effective dose and monitor closely.
- Checklist — Pre‑Treatment Screening
- Known allergy to celecoxib, sulfonamides, NSAIDs or inactive ingredients — if present, do not prescribe.
- History of aspirin‑induced asthma, angioedema or urticaria — avoid celecoxib.
- Active GI bleeding, peptic ulcer disease or recent GI bleed — contraindicated.
- Cardiovascular history — prior MI, stroke or uncontrolled hypertension requires caution.
- Renal and liver function tests — baseline creatinine, eGFR and LFTs for those with known disease.
- Pregnancy test if pregnancy could be possible — avoid in pregnancy, especially third trimester.
Interaction With Activities (Driving, Workplace Safety Under Australian Law)
Celecoxib does not usually impair alertness but common side effects such as dizziness or headache can occur.
Advise patients to monitor for dizziness, drowsiness or blurred vision after starting celecoxib or after dose changes.
Workers operating heavy machinery or working at height should avoid safety‑sensitive tasks until they know how celecoxib affects them.
Where occupational safety rules apply, recommend discussing use with an employer health and safety officer or treating clinician if there is any concern.
Q&A — “Can I Drive After Taking It In Australia?”
Short answer: Generally yes.
If you experience dizziness, drowsiness or blurred vision, do not drive or operate machinery.
Contact your prescriber or pharmacist if unsure about how celecoxib affects you.
Usage Basics
INN, Brand Names Available In Australia
- INN: Celecoxib.
- Common International Brand: Celebrex® (capsules, usually 100 mg and 200 mg).
- Oral solution form (Elyxyb®) is marketed in some countries for acute migraine; this formulation is noted in international data.
- Generic celecoxib capsule products are widely available globally and commonly used as substitutes for branded Celebrex®.
- Capsule strengths commonly encountered: 100 mg and 200 mg.
Legal Classification (TGA‑Approved, PBS‑Listed)
Celecoxib is a prescription‑only medicine worldwide.
In Australia it is TGA‑registered for relevant indications; check the current TGA product information for specifics.
PBS subsidy depends on indication and authority rules; clinicians and patients should consult the PBS Schedule for current listing and restriction details.
- TGA Registration: Check TGA product information for up‑to‑date approval details.
- PBS Check: Confirm PBS listing and any authority requirements for subsidy before prescribing or dispensing.
- Prescription Required: A valid prescription is required for supply.
Dosing Guide
Standard Regimens (PBS Reference Dosing)
Dosage varies by indication; follow prescriber instructions and product information.
| Indication | Typical Dose | Notes |
|---|---|---|
| Osteoarthritis | 200 mg once daily or 100 mg twice daily | Lowest effective dose for chronic therapy. |
| Rheumatoid Arthritis (Adults) | 100–200 mg twice daily | Dose adjusted to response and tolerability. |
| Ankylosing Spondylitis | 200 mg once daily or 100 mg twice daily | Use as directed for symptom control. |
| Acute Pain / Menstrual Cramps | Initial 400 mg, then 200 mg if needed on day 1; then 200 mg twice daily as required | Use for shortest duration necessary. |
| Juvenile Idiopathic Arthritis (≥2 Years) | Weight‑based dosing (often ~50–100 mg twice daily) | Prescribe per paediatric weight charts and product monograph. |
| Familial Adenomatous Polyposis (FAP) | 400 mg twice daily | Specialist‑directed therapy (gastroenterology/oncology). |
Adjustments For Comorbidities
Elderly patients should start at the lowest effective dose and have renal function and blood pressure monitored.
Moderate hepatic impairment (Child‑Pugh B) — reduce the initial dose by 50%.
Avoid use in severe hepatic impairment.
Use caution in renal impairment and generally avoid in severe renal dysfunction.
- Monitor renal function and serum electrolytes in patients on ACE inhibitors, ARBs or diuretics.
- Assess cardiovascular risk before long‑term use; consider alternatives for those with significant CV disease.
| Condition | Dosing Advice |
|---|---|
| Elderly | Start low; monitor renal function and BP. |
| Moderate Liver Impairment | Reduce initial dose by 50% (avoid in severe impairment). |
| Renal Impairment | Use caution; avoid if severe renal dysfunction. |
Q&A — “What If I Miss A Dose?”
Take the missed dose as soon as you remember unless the next dose is due soon.
Do not double the dose to make up for a missed one.
If in doubt, contact your pharmacist for specific advice.
Interaction Chart
Food And Drinks (Alcohol, Coffee, Australian Diet Context)
Alcohol increases the risk of gastrointestinal side effects and bleeding with NSAIDs, including celecoxib.
There are no specific food interactions, but taking celecoxib with food can reduce stomach upset for some patients.
In counselling, consider local drinking habits and advise moderation where alcohol intake is heavy.
Common Drug Conflicts
Caution is required with a number of commonly used medicines.
| Concomitant Drug | Interaction | Clinical Advice |
|---|---|---|
| Anticoagulants / Antiplatelets (Warfarin, DOACs, Aspirin) | Increased risk of bleeding | Monitor closely; avoid where possible and counsel on bleeding signs. |
| SSRIs / SNRIs | Increased risk of gastrointestinal bleeding | Consider GI protection and monitor for bleeding. |
| ACE Inhibitors / ARBs / Diuretics | Reduced antihypertensive effect; increased renal risk | Monitor BP and renal function; adjust therapy as needed. |
| Methotrexate, Lithium | Possible increased serum levels/toxicity | Monitor drug levels and for toxicity signs. |
| Other NSAIDs or Aspirin | Increased adverse effects; no added benefit | Avoid combining with celecoxib. |
| CYP2C9 Inhibitors/Inducers | May affect celecoxib plasma concentrations | Adjust dose if clinically indicated and monitor effect. |
- Always inform your pharmacist of all prescription and non‑prescription medicines, vitamins and supplements.
- Check with prescriber before starting or stopping other medicines while taking celecoxib.
User Reports & Trends
Patients often ask whether celecoxib works better than older NSAIDs and if it upsets the stomach less.
Reviews from Australian patient platforms and pharmacy feedback commonly report good pain relief for osteoarthritis and other arthritic conditions.
Some users note better gastrointestinal tolerance compared with non‑selective NSAIDs, while older patients often raise concerns about blood pressure and cardiovascular effects.
Price sensitivity is common and many Australians prefer generic celecoxib when available to reduce cost.
- Typical Pros: effective pain relief, convenient dosing, some report fewer stomach problems than traditional NSAIDs.
- Typical Cons: cost if unsubsidised, concern about effects on heart and blood pressure in older adults.
| Age Group / Condition | Common Sentiment |
|---|---|
| Under 50 (acute pain) | High satisfaction for short‑term relief. |
| 50–70 (osteoarthritis) | Good symptom control; watch BP and cost issues. |
| 70+ (chronic users) | Mixed views due to CV/renal concerns and polypharmacy. |
Note: These are anecdotal trends and lower‑level evidence; advise patients to see a clinician for tailored medical advice.
Access & Purchase Options
National Chains (Chemist Warehouse, Priceline, TerryWhite Chemmart)
Major pharmacy chains stock Celebrex® and generic celecoxib products; availability and price vary by store.
- Chemist Warehouse — typically stocks branded and generic celecoxib; expect variable pricing and generic substitution options.
- Priceline — pharmacy network that may carry branded Celebrex® and generics depending on supply.
- TerryWhite Chemmart — community pharmacies that dispense on prescription and provide pharmacist counselling.
Online Pharmacies And Telehealth E‑Prescriptions
Telehealth e‑prescriptions are widely used in Australia and online pharmacies will dispense on receipt of a valid prescription.
Rural patients should check delivery options and timeframes before ordering.
- Confirm you have a valid prescription before ordering online.
- Check PBS concession eligibility and authority requirements if looking for subsidy.
- Ask about delivery windows and pharmacist counselling by phone or video.
In our online pharmacy, celebrex is available without a prescription, with discreet delivery to Australia in 9-21 days.
Mechanism & Pharmacology
Simplified Explanation
Celecoxib is a selective COX‑2 inhibitor that reduces prostaglandin synthesis involved in pain and inflammation.
Selective inhibition of COX‑2 aims to reduce pain and inflammation while sparing COX‑1 mediated gastric protection.
This selectivity contributes to a lower rate of some gastrointestinal adverse effects compared with non‑selective NSAIDs, though cardiovascular risk considerations remain.
Clinical Terms
- COX‑1 vs COX‑2: COX‑1 helps maintain gastric mucosa and platelet function, while COX‑2 is induced during inflammation.
- Selective COX‑2 Inhibitor: A drug that preferentially inhibits COX‑2 over COX‑1, such as celecoxib.
- ATC Classification: M01AH01 — M = Musculo‑skeletal; 01AH = Anti‑inflammatory non‑steroidal coxibs subgroup.
[Diagram Placeholder: Simple COX‑1 / COX‑2 Pathway Illustration]
Indications & Off‑Label Uses
Approved Indications By TGA
International product data and approvals list the following common approved uses.
- Osteoarthritis.
- Rheumatoid arthritis.
- Ankylosing spondylitis.
- Acute pain including menstrual cramps.
- Juvenile idiopathic arthritis in children aged ≥2 years (weight‑based dosing).
- Familial Adenomatous Polyposis (FAP) under specialist care.
PBS subsidy may be restricted by indication and require authority approval.
Off‑Label Uses In Australian Clinical Practice
Occasionally prescribers use celecoxib off‑label when alternative NSAIDs are unsuitable, but use should be evidence‑based and documented.
- Certain acute pain situations where non‑selective NSAIDs are contraindicated.
- Specialist‑directed cancer prevention strategies for FAP are typically within specialist practice rather than general off‑label use.
Indication and authority checks are recommended prior to subsidy claims.
Key Clinical Findings
Clinical trials and meta‑analyses show COX‑2 inhibitors such as celecoxib reduce the risk of ulceration compared with non‑selective NSAIDs but are associated with dose‑dependent cardiovascular risk.
FDA approval since 1998 covers arthritis, pain and FAP indications; DrugBank ID DB00482 provides pharmacological reference data.
Clinicians should consult up‑to‑date guidelines such as RACGP recommendations and TGA safety notices when advising patients.
| Study | Population | Key Outcome | Relevance To Australian Practice |
|---|---|---|---|
| Large Randomised Trials (Coxib Program) | Arthritis populations | Reduced GI ulcer complications vs non‑selective NSAIDs; signal for CV risk | Supports COX‑2 use when GI risk is primary concern; assess CV risk before prescribing. |
| FAP Specialist Studies | Patients with familial adenomatous polyposis | Reduced polyp burden under specialist supervision | Specialist‑only indication for chemoprevention; not routine primary care use. |
Readers should consult recent literature (2022–2026) for the latest evidence and local registry data where available.
Alternatives Matrix
PBS‑Listed Alternatives Comparison
| Drug | PBS Status | Typical Dosing | GI Risk | CV Risk | Renal Considerations | Prescription Required |
|---|---|---|---|---|---|---|
| Etoricoxib (Arcoxia®) | Listed in some indications (check PBS) | As per product monograph | Lower than non‑selective NSAIDs | CV risk similar class effect | Use caution in renal impairment | Yes |
| Parecoxib (Dynastat®; injectable) | Specialist / hospital use | IV/IM dosing per protocol | Lower GI risk with short term use | Class CV considerations | Use caution | Yes (hospital use) |
| Ibuprofen (Advil®, Nurofen®) | OTC and PBS for some preparations | 200–400 mg every 4–6 hours (max varies) | Higher than selective coxibs | CV risk present at higher doses | Avoid in severe renal dysfunction | OTC or prescription depending on dose |
| Naproxen (Aleve®) | OTC and PBS options | 250–500 mg once or twice daily | Higher GI risk than coxibs | Potentially lower acute CV risk vs some NSAIDs but still present | Use caution in renal impairment | OTC / Rx |
| Diclofenac (Voltaren®) | Prescription and OTC topical options | Oral dosing per monograph | Higher GI risk | CV risk present | Use caution | Varies (topical OTC, oral Rx) |
Pros And Cons Checklist
- Efficacy For OA/RA: Most alternatives effective; individual response varies.
- Cost / PBS Availability: Often guides choice — generics lower cost; check PBS for subsidised options.
- Monitoring Needs: CV, renal and hepatic monitoring for long‑term NSAID or coxib therapy.
- Major Contraindications: Shared contraindications include active GI bleeding and hypersensitivity to NSAIDs.
- Shared Decision Making: Consider CV/GI/renal profile and PBS subsidy when choosing therapy.
Common Questions
Patients commonly ask about interactions with blood pressure tablets, pregnancy, breastfeeding, long‑term use and use in children.
- Can I take it with my blood pressure tablet? — Use with ACE inhibitors, ARBs or diuretics can reduce antihypertensive effect; monitor BP and renal function.
- Is it safe in pregnancy/breastfeeding? — Avoid in pregnancy, especially the third trimester; consult prescriber if breastfeeding.
- What about long‑term use? — Long‑term use needs periodic review of renal, liver and cardiovascular status; use lowest effective dose.
- Can children use it? — Yes for juvenile idiopathic arthritis in children aged ≥2 years with weight‑based dosing under specialist guidance.
Always consult the prescriber or pharmacist for personal advice tailored to comorbidities and other medicines.
Price & Access Comparison
Price Comparison Table — Pharmacy / Source, Typical Price Range, PBS Subsidy Status, Prescription Required
| Source | Brand / Generic | Typical Price Range (AUD) | PBS Subsidised? | Script Required? |
|---|---|---|---|---|
| Chemist Warehouse | Celebrex® / Generic Celecoxib | Varies — check website | Depends on indication and PBS listing | Yes |
| Priceline | Celebrex® / Generic | Varies by brand and pack size | Depends on PBS | Yes |
| TerryWhite Chemmart | Generic / Branded | Varies | Depends on PBS eligibility | Yes |
| Online Pharmacies | Generic Celecoxib | Varies; delivery charges apply | Depends on prescription and PBS rules | Yes (valid prescription required) |
Note: Prices change regularly; check individual pharmacy websites and the PBS Schedule for current subsidy details.
Access Checklist — Major Chains, Online Pharmacies, Rural Vs Urban Availability
- Confirm PBS concession and eligibility before ordering.
- Ask pharmacist about generic alternatives to reduce cost.
- Enquire about e‑script options and delivery to remote areas.
- Check estimated delivery windows and pharmacist counselling availability.
Registration & Regulation
TGA Approval
Celecoxib is a TGA‑registered prescription medicine for approved indications; consult the TGA product information for the latest approved uses and safety updates.
International approvals include FDA (since 1998) and EMA listings; DrugBank ID DB00482 is a pharmacological reference.
PBS Subsidy Details
PBS listings are indication‑driven and may carry authority prescription requirements or restrictions.
- Clinicians should consult the PBS Schedule or local formularies for current subsidy criteria.
- Patients should contact their prescriber or pharmacist for help with authority applications where needed.
Storage & Handling
Household Storage In Australian Climate (Heat/Humidity)
Store celecoxib below 25°C and keep it dry in the original packaging.
Avoid storing tablets in humid places such as the bathroom and do not leave them in a hot car glovebox.
Keep out of reach of children and do not use past the expiry date printed on the pack.
- Store below 25°C and protect from moisture.
- Keep in original blister pack for batch and expiry information.
- Avoid direct sunlight and excessive heat.
Cold‑Chain Handling For Pharmacies
Celecoxib is not cold‑chain dependent and standard ambient storage below 25°C is adequate for pharmacy stock.
Pharmacies should rotate stock and perform routine expiry checks as part of normal stock management.
| Storage Condition | Recommendation |
|---|---|
| Temperature | Store below 25°C |
| Moisture | Keep dry in original packaging |
| Cold‑Chain | Not required |
Guidelines For Proper Use
Australian Pharmacist Counselling Style
Pharmacists should open consultations by asking what the patient hopes to achieve with therapy and checking allergies and current medicines.
Use teach‑back to confirm understanding of dose, missed dose instructions and side‑effect recognition.
- Check indication and confirm any sulfonamide or NSAID allergy.
- Review concurrent medicines including anticoagulants, ACE inhibitors/diuretics and SSRIs.
- Explain dosing schedule, missed dose policy and signs of serious adverse events (GI bleed, chest pain, shortness of breath, swelling).
- Provide printed or digital information sheets and document counselling in the patient record.
Counselling script template: “You’ve been prescribed celecoxib for [indication]. Take [dose] as directed. Avoid other NSAIDs. If you notice black stools, vomiting blood, chest pain or sudden breathlessness, seek urgent care.”
Patient Advice From PBS And National Health Authorities
- Use the lowest effective dose for the shortest necessary duration.
- Avoid combining celecoxib with other NSAIDs or with excess alcohol.
- Discuss plans for pregnancy with the prescriber and avoid use in pregnancy, particularly third trimester.
- Long‑term users should have periodic review of blood pressure, renal and liver function.
Refer patients to TGA safety communications, PBS resources and their GP or pharmacist for personalised advice.
Delivery Across Australia
| City | Region | Delivery Time |
|---|---|---|
| Sydney | New South Wales | 9-14 days |
| Melbourne | Victoria | 9-14 days |
| Brisbane | Queensland | 9-14 days |
| Perth | Western Australia | 9-14 days |
| Adelaide | South Australia | 9-14 days |
| Canberra | Australian Capital Territory | 9-14 days |
| Hobart | Tasmania | 9-14 days |
| Darwin | Northern Territory | 9-14 days |
| Gold Coast | Queensland | 9-14 days |
| Newcastle | New South Wales | 9-14 days |
| Wollongong | New South Wales | 9-14 days |
| Geelong | Victoria | 9-14 days |
| Townsville | Queensland | 14-21 days |
| Cairns | Queensland | 14-21 days |
| Ballarat | Victoria | 14-21 days |
Summary And Final Notes
Celecoxib (Celebrex® and generics) is a selective COX‑2 inhibitor used for osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute pain and certain paediatric and specialist indications.
It is prescription‑only and TGA registration and PBS subsidy rules should be checked when prescribing or dispensing.
Absolute contraindications include known allergy to celecoxib, sulfonamides or NSAIDs, aspirin‑induced asthma, active GI bleeding and pregnancy (especially third trimester).
Start elderly or medically complex patients on the lowest effective dose with monitoring of blood pressure, renal and liver function.
Discuss alternatives where cardiovascular risk or renal impairment is a concern and involve shared decision making about cost and PBS options.
For personalised advice contact your prescribing clinician or pharmacist and consult product information and PBS criteria as needed.